Clinical Trial Update: Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for expanded allogenic adipose-derived stem cells (Cx601) in complex perianal fistulas associated with Crohn's disease; study phases 1/2 c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Fistula
• Crohn Disease

Drugs mentioned

• Cx601 (expanded allogenic adipose-derived stem cells) (expanded allogenic adipose-derived stem cells)

Snippet

Sponsor: Tigenix S.A.U. | Conditions: Crohn's Disease, Anal Fistula | Phase 1, Phase 2 | Status: COMPLETED